Skip to content

INNOVAGE HOLDING CORP (INNV) — insider trading

Health Care · NASDAQ

INNOVAGE HOLDING CORP (INNV) has 25 reported SEC Form 4 insider transactions in our data, including 4 open-market sales among the most recent 25 (latest 2026-09-25).

Recent Form 4 transactions

DateInsiderRoleTypeSharesPriceValueFiling
2026-09-25 DAMATO NICOLE Officer (CHIEF LEGAL OFFICER) Open-market sale 23,814 $8.70 $207.2K Form 4
2026-09-24 TCO GROUP HOLDINGS, L.P. 10% owner Open-market sale 10,000,000 $9.25 $92.50M Form 4
2026-09-24 Welsh, Carson, Anderson & Stowe XII, L.P.; WCAS CO-INVEST ASSOCIATES LLC; Welsh, Carson, Anderson & Stowe XII Delaware, L.P.; Welsh, Carson, Anderson & Stowe XII Delaware II, L.P.; Welsh, Carson, Anderson & Stowe XII Cayman, L.P.; WCAS XII Co-Investors LLC; WCAS MANAGEMENT CORP; WCAS - CO-INVEST HOLDCO, L.P.; WCAS XII ASSOCIATES LLC; WCAS XII ASSOCIATES CAYMAN, L.P. 10% owner Open-market sale 10,000,000 — $0 Form 4
2026-09-24 IGNITE AGGREGATOR LP; APAX X (GUERNSEY) USD AIV LP; IGNITE GP INC.; Apax X EUR L.P.; Apax X USD L.P.; Apax X GP Co. Ltd 10% owner Open-market sale 10,000,000 $9.25 $92.50M Form 4
2026-09-03 TCO GROUP HOLDINGS, L.P. 10% owner Other acquisition or disposition 411,515 — $0 Form 4
2026-09-03 Welsh, Carson, Anderson & Stowe XII, L.P.; WCAS CO-INVEST ASSOCIATES LLC; Welsh, Carson, Anderson & Stowe XII Delaware, L.P.; Welsh, Carson, Anderson & Stowe XII Delaware II, L.P.; Welsh, Carson, Anderson & Stowe XII Cayman, L.P.; WCAS XII Co-Investors LLC; WCAS MANAGEMENT CORP; WCAS - CO-INVEST HOLDCO, L.P.; WCAS XII ASSOCIATES LLC; WCAS XII ASSOCIATES CAYMAN, L.P. 10% owner Other acquisition or disposition 411,515 — $0 Form 4
2026-09-03 IGNITE AGGREGATOR LP; APAX X (GUERNSEY) USD AIV LP; IGNITE GP INC.; Apax X EUR L.P.; Apax X USD L.P.; Apax X GP Co. Ltd 10% owner Other acquisition or disposition 411,515 — $0 Form 4
2026-07-27 BLAIR PATRICK T Officer (CHIEF EXECUTIVE OFFICER) Grant / award / vesting 78,397 — $0 Form 4
2026-07-22 Delk Meredith Officer (Chief Administrative Officer) Grant / award / vesting 42,808 — $0 Form 4
2026-07-22 DAMATO NICOLE Officer (CHIEF LEGAL OFFICER) Grant / award / vesting 51,369 — $0 Form 4
2026-07-22 Adams Benjamin C Officer (CHIEF FINANCIAL OFFICER) Grant / award / vesting 17,123 — $0 Form 4
2026-07-16 BLAIR PATRICK T Officer (CHIEF EXECUTIVE OFFICER) Shares withheld for taxes / exercise cost 14,453 $11.87 $171.6K Form 4
2026-07-15 DAMATO NICOLE Officer (CHIEF LEGAL OFFICER) Shares withheld for taxes / exercise cost 19,401 $11.58 $224.7K Form 4
2026-07-01 CARLSON JAMES G Director Grant / award / vesting 8,539 — $0 Form 4
2026-07-01 FONTNEAU PATRICIA Director Grant / award / vesting 8,539 — $0 Form 4
2026-07-01 Bush John Ellis Director Grant / award / vesting 8,539 — $0 Form 4
2026-07-01 Kennedy Edward Moore Jr. Director Grant / award / vesting 8,539 — $0 Form 4
2026-07-01 Sparks Teresa Director Grant / award / vesting 8,539 — $0 Form 4
2026-07-01 TAVENNER MARILYN B Director Grant / award / vesting 8,539 — $0 Form 4
2026-07-01 ZORETIC RICHARD C Director Grant / award / vesting 8,539 — $0 Form 4
2026-06-08 Browne Jennifer Officer (President and COO) Grant / award / vesting 67,842 — $0 Form 4
2026-06-06 BLAIR PATRICK T Officer (CHIEF EXECUTIVE OFFICER) Shares withheld for taxes / exercise cost 10,088 $7.30 $73.6K Form 4
2026-06-06 DAMATO NICOLE Officer (CHIEF LEGAL OFFICER) Shares withheld for taxes / exercise cost 8,018 $7.30 $58.5K Form 4
2026-06-05 BLAIR PATRICK T Officer (CHIEF EXECUTIVE OFFICER) Shares withheld for taxes / exercise cost 11,881 $7.30 $86.7K Form 4
2026-06-04 DAMATO NICOLE Officer (CHIEF LEGAL OFFICER) Shares withheld for taxes / exercise cost 15,046 $7.20 $108.3K Form 4

Ask the chat about INNV's insider activity →

Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.

Source: SEC EDGAR Form 3/4/5. See the full company profile: INNOVAGE HOLDING CORP (INNV).

Last updated 2026-09-25 (most recent filing date).

Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.